SCHEMBL29966497

SCHEMBL29966497

Cn1nc(Br)c2ncn(CC(=O)NC3CCC(OC(F)F)CC3)c(=O)c21

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.43
KMT2A Q03164 2/20 0.41
RXFP1 Q9HBX9 1/20 0.41
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
MEN1 O00255 1/20 0.37
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.35
GRIN2B Q13224 5/20 0.35
F2 P00734 1/20 0.35
ABL1 P00519 1/20 0.35
GAA P10253 1/20 0.35
NPSR1 Q6W5P4 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TRPA1 O75762 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24750405 1.00 LMNA (0.43) LMNAKMT2ARXFP1NPC1RAB9A
SCHEMBL24750368 0.89 LMNA (0.40) LMNAKMT2ARXFP1NPC1RAB9A
SCHEMBL24750376 0.81 CCR2 (0.38) LMNAKMT2ARXFP1ABL1
SCHEMBL29965144 0.81 CCR2 (0.38) LMNAKMT2ARXFP1ABL1
SCHEMBL24750365 0.81 CCR2 (0.38) LMNAKMT2ARXFP1ABL1
SCHEMBL24750658 0.80 EPHX2 (0.37) LMNAKMT2ARXFP1NPC1RAB9A
SCHEMBL29965806 0.80 EPHX2 (0.38) LMNAKMT2ARXFP1NPC1RAB9A
SCHEMBL24750382 0.80 EPHX2 (0.37) LMNAKMT2ARXFP1NPC1RAB9A
SCHEMBL24750372 0.80 EPHX2 (0.38) LMNAKMT2ARXFP1NPC1RAB9A
SCHEMBL29965867 0.80 EPHX2 (0.37) LMNAKMT2ARXFP1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4313988-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS Orphagen Pharmaceuticals, Inc. (US) 2024-02-07 EP disclosed
WO-2022204481-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS Orphagen Pharmaceuticals, Inc. (US) 2022-09-29 WO disclosed